HIV in pregnancy is highly manageable with modern care. If you're pregnant and living with HIV, taking HIV treatment (ART) and reaching an undetectable viral load dramatically lowers the chance of passing the virus to your baby. Universal screening, lifelong treatment, and careful delivery planning together make a healthy pregnancy and a healthy baby the expected outcome.
Key figures
- Acute symptoms
- 2–4 wks
- flu-like; many have none
- NAT detects
- 10–33 days
- Antibody test
- 23–90 days
- U=U
- no transmission
- when undetectable
| Item | Value |
|---|---|
| Acute symptoms | 2–4 wks: flu-like; many have none |
| NAT detects | 10–33 days |
| Antibody test | 23–90 days |
| U=U | no transmission: when undetectable |
Why HIV matters during pregnancy
HIV is a virus that attacks the immune system, specifically the CD4 cells that coordinate your body's defenses CDC. Left untreated, it moves through three stages: an acute phase with a very high viral load, a long chronic phase (clinical latency) where the virus stays active but quiet, and finally AIDS, the most severe stage, defined by a CD4 count under 200 cells/mm³ or an opportunistic infection. There's no cure, but with treatment people live long, healthy lives CDC.
Pregnancy is one of the three ways HIV can pass to another person: perinatal transmission, meaning during pregnancy, childbirth, or breastfeeding. The other routes are sex and shared injection equipment. The fluids that carry HIV are blood, semen, vaginal fluid, rectal fluid, and breast milk CDC. Prenatal care leans heavily on knowing your status, because the earlier HIV is found and treated, the more there is to gain for both you and your baby.
The single most important fact here is U=U, undetectable equals untransmittable. A person who takes HIV medicine as prescribed and keeps an undetectable viral load does not transmit HIV to sex partners, and a low viral load is also central to protecting a baby. Trial data backs this. Across the PARTNER studies, mixed-status couples logged tens of thousands of condomless sex acts with zero linked HIV transmissions when the positive partner was undetectable PARTNER.
What are the risks to the baby?
Without treatment, HIV can cross to the baby during pregnancy, at delivery, when the baby is exposed to maternal blood and fluids, or afterward through breast milk. Delivery is the highest-risk window. The mother's viral load drives that risk: how much virus is circulating in the blood and genital fluids. A high viral load means high risk, and an undetectable viral load drops that risk to very low levels.
Controlling the virus matters most. Most people who start ART reach an undetectable viral load within months, and getting there before delivery is the goal your care team works toward. The same biology behind U=U for sexual partners, where less virus means less to transmit, protects your baby through pregnancy and birth.
When is HIV screening done in pregnancy?
The U.S. Preventive Services Task Force gives HIV screening a Grade A recommendation: screen everyone ages 15 to 65 at least once, and repeat for anyone at increased risk USPSTF. HIV testing is a routine, opt-out part of the first prenatal visit for every pregnant person, not a test reserved for people who feel at risk. The CDC recommends at least annual testing for those with ongoing risk CDC.
If your first-trimester test is negative but you have risk factors, your clinician may retest later in pregnancy, because catching a new infection still leaves time to act. Acute HIV is easy to miss and highly contagious. Most people develop flu-like symptoms two to four weeks after infection, fever, rash, sore throat, swollen lymph nodes, night sweats, right when the viral load peaks above a million copies/mL HHS. If you've had a possible exposure recently, don't wait for a routine prenatal test; read when to test after exposure and arrange to get tested promptly.
Is HIV treatment safe in pregnancy?
Everyone with HIV should take ART and start as soon as possible after diagnosis, including during pregnancy, because the benefits to your health and your baby's far outweigh the risks. ART is a combination of HIV medicines, available as single pills or multi-pill regimens, drawn from drug classes including integrase inhibitors, NRTIs, NNRTIs, and protease inhibitors. Your obstetric and HIV teams choose a regimen with a strong pregnancy safety record and good ability to suppress the virus fast.
If you were already on treatment before conceiving, most people continue an effective regimen rather than switching, since you want an undetectable viral load carried into pregnancy. If your virus isn't fully suppressed, your team will look at why: adherence, the regimen itself, or HIV drug resistance, where the virus has mutations that blunt certain drugs and call for a tailored combination. Resistance testing guides those decisions.
On newer options: long-acting injectable HIV treatment is changing maintenance therapy for many adults, but during pregnancy the pillars remain a well-studied oral regimen taken every day, close viral-load monitoring, and prompt action if numbers don't fall. Lifelong treatment is the standard, and modern HIV care is compatible with a near-normal lifespan. A 20-year-old who starts treatment before their CD4 falls below 200 now has a life expectancy approaching the general population's Lancet HIV.
Reducing transmission at delivery
Delivery is the highest-risk moment, so the plan is built around your viral load near term. When the virus is well suppressed, a vaginal birth is generally appropriate; when it isn't, your team weighs additional measures to limit the baby's exposure to maternal blood and fluids. Newborns also receive preventive HIV medicine after birth as a standard safeguard, and the baby is tested over the following weeks and months to confirm their status.
Feeding is part of this conversation. Breast milk can carry HIV, so feeding choices are made with your care team based on your viral load and your circumstances. Keep the virus undetectable and follow the delivery and newborn-care plan, and the odds tilt strongly toward a baby born without HIV.
What if I might have just been exposed?
If you think you were exposed to HIV, a condom failure, a needle, an assault, treat it as an emergency rather than waiting to test. Post-exposure prophylaxis (PEP) is a 28-day course of medicine that must start within 72 hours of exposure; in the original occupational study it cut seroconversion by about 81% CDC. The sooner it starts, the better it works, so head to urgent care or an ER the same day. Going forward, PrEP, pre-exposure prophylaxis, prevents HIV before exposure and reduces risk from sex by about 99% when taken as prescribed CDC. Both are worth discussing with your clinician if you're pregnant and at ongoing risk.
PEP vs. PrEP at a glance
| PEP (after exposure) | PrEP (before exposure) | |
|---|---|---|
| Who it's for | Someone HIV-negative after a possible exposure | Someone HIV-negative with ongoing risk |
| Timing | Must start within 72 hours; taken daily for 28 days | Ongoing, daily pill or a long-acting shot |
| Purpose | Emergency prevention for one exposure | Continuous protection over time |
When to see a clinician
See a clinician if you're pregnant or planning a pregnancy and haven't been tested for HIV, if you've had a possible exposure within the last three days (same-day, for PEP), or if you're living with HIV and want to start or optimize treatment before or during pregnancy. Get care promptly if you develop flu-like symptoms after a recent risk, since that pattern can signal acute infection, when intervention matters most.
Think about the long view too. HIV care continues long after delivery, and support needs change across a lifetime; the hardships of aging with HIV are ones that early, consistent care can help soften. The earlier you engage, the more options you have.
Keep exploring on EasySTD: which STD test you need, your risk of an STD and HIV/AIDS testing.